Literature DB >> 4466304

Behavior of pancreatic glucagon, insulin, and HGH in liver cirrhosis, after arginine and I.V. glucose.

A V Greco, G Ghirlanda, C Patrono, G Fedili, R Manna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4466304     DOI： 10.1007/bf02581236

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN： 0001-5563


× No keyword cloud information.
  37 in total

1.  The glucose metabolism of patients with malignant disease and of normal subjects as studied by means of an intravenous glucose tolerance test.

Authors:  P A MARKS; J S BISHOP
Journal:  J Clin Invest       Date:  1957-02       Impact factor: 14.808

2.  Hormone excretion in liver disease.

Authors:  F C DOHAN; E M RICHARDSON; L W BLUEMLE; P GYORGY
Journal:  J Clin Invest       Date:  1952-05       Impact factor: 14.808

3.  Growth hormone and protein-calorie malnutrition. Impaired suppression during induced hyperglycaemia.

Authors:  B Pimstone; G Barbezat; J D Hansen; P Murray
Journal:  Lancet       Date:  1967-12-23       Impact factor: 79.321

Review 4.  [The intravenous tolbutamide test].

Authors:  P Rambert; F Thervet
Journal:  Journ Annu Diabetol Hotel Dieu       Date:  1968

5.  The behaviour of insulinaemia in patients ith liver cirrhosis after intravenous administration of glucose, tolbutamide and glucagon.

Authors:  T Kasperska; J Lawecki; H Rogala; A Czyzyk
Journal:  Diabetologia       Date:  1971-10       Impact factor: 10.122

6.  [Somatotropic function of the cirrhotic patient].

Authors:  B Rüedi; M Aubert; G A Borel; P Magnenat; J P Felber
Journal:  Schweiz Med Wochenschr       Date:  1969-07-26

7.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

8.  Decreased insulin production, elevated growth hormone levels, and glucose intolerance in liver disease.

Authors:  A Hernandez; E Zorrilla; H Gershberg
Journal:  J Lab Clin Med       Date:  1969-01

9.  [Intravenous tolbutamide test during hepatic disorders of chronic alcoholism].

Authors:  A Cruz; H David; F Thervet; P Rambert; H Benard
Journal:  Diabete       Date:  1969 Jan-Mar

10.  Azotemia and glucose intolerance.

Authors:  J M Cerletty; N H Engbring
Journal:  Ann Intern Med       Date:  1967-06       Impact factor: 25.391
View more
  11 in total

1.  Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis.

Authors:  A V Greco; F Crucitti; G Ghirlanda; R Manna; L Altomonte; A G Rebuzzi; A Bertoli
Journal:  Diabetologia       Date:  1979-07       Impact factor: 10.122

2.  Somatostatin infusion in liver cirrhosis: glucagon control of glucose homeostasis.

Authors:  A V Greco; L Altomonte; G Ghirlanda; A G Rebuzzi; R Manna; A Bertoli
Journal:  Diabetologia       Date:  1980-03       Impact factor: 10.122

3.  Effect of somatostatin (SRIF) on plasma glucose and insulin response to glucagon in liver cirrhosis.

Authors:  L Altomonte; A V Greco; G Ghirlanda; A G Rebuzzi; R Manna; A Bertoli
Journal:  Acta Diabetol Lat       Date:  1979 Apr-Jun

4.  Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions.

Authors:  A V Greco; G Mingrone; A Mari; E Capristo; M Manco; G Gasbarrini
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

5.  C-peptide in non-alcoholic cirrhosis and hepatocellular carcinoma.

Authors:  K K Pun; P W Ho; R T Yeung
Journal:  J Endocrinol Invest       Date:  1988-05       Impact factor: 4.256

6.  Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.

Authors:  L Gerö; L Korányi; F Szalay; B Büki; G Tamás
Journal:  Acta Diabetol Lat       Date:  1982 Jan-Mar

7.  Serum levels of true insulin, C-peptide and proinsulin in peripheral blood of patients with cirrhosis.

Authors:  T Kasperska-Czyźykowa; L G Heding; A Czyzyk
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

8.  Changes in immunoreactive insulin, C-peptide immunoreactivity, and immunoreactive glucagon in acute viral hepatitis.

Authors:  K Kaneko; M Arai; H Funatomi; Y Hatta; K Mitamura
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

9.  Impaired glucose tolerance and growth hormone in chronic liver disease.

Authors:  W J Riley; V J McCann
Journal:  Gut       Date:  1981-04       Impact factor: 23.059

10.  Hyperglucagonaemia in cirrhosis. Relationship to hepatocellular damage.

Authors:  G Smith-Laing; H Orskov; M B Gore; S Sherlock
Journal:  Diabetologia       Date:  1980-08       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.